Neudle.com: multiple sclerosis risk factors for

Differential
(Click to cross reference)

abortion, spontaneous

acetylcholine receptor

acetylcholine receptor antibody

activities of daily living

activities of daily living scale

adalimumab

advances in neurology

adverse drug reaction

amyotrophic lateral sclerosis

analgesic

angiography, cerebral

anosmia

anterior horn cell disease

anti JC virus antibodies

antibiotic prophylaxis

antibiotics

anticoagulant, contraindications

anticoagulant, treatment

anticoagulant, treatment in CVD

anticonvulsants, effectiveness

anticonvulsants, selection of

antiviral agents

Apgar score

arrhythmia, cardiac

arteriovenous malformation, cerebral

autonomic dysfunction

azathioprine

B cell lymphocyte depletion

B cell lymphocytes

bacterial infection

bacterial infection, CNS

Barkhof MR criteria for MS

behavior modification

blood dyscrasias, neurologic findings with

bone marrow biopsy

bone scanning

bone survey

Borrelia burgdorferi infection

brain atrophy

brain biopsy

brain biopsy, false negative

brain biopsy, negative

Call-Fleming syndrome

cancer, cerebrovascular accident complicating patients with

candida albicans

cannabinoids

carcinoma

cardiovascular disease

central nervous system, infection of

cerebral arteries

cerebral edema

cerebral hypersensitivity, delayed

cerebral infarction, hemorrhagic

cerebral palsy

cerebral palsy, risk factors

cerebral venous thrombosis

cerebral venous thrombosis, deep

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, culture of

cerebrospinal fluid, gammaglobulin of

cerebrospinal fluid, oligoclonal IgG in

cerebrospinal fluid, proteincytologic dissociation

cerebrovascular accident

cerebrovascular accident, arterial occlusion, location

cerebrovascular accident, classification

cerebrovascular accident, etiology

cerebrovascular accident, incidence of

cerebrovascular accident, neonatal

cerebrovascular accident, prevention of

cerebrovascular accident, prognosis in

cerebrovascular accident, recurrent

cerebrovascular accident, thrombolytic agents in treatment

cerebrovascular accident, women

cerebrovascular accident, work up for

cerebrovascular disease, risk factors in

channelopathy

chemotherapy, CNS treatment and complications with

child abuse

children

chiropractic manipulation

concentration, impaired

confusion

congenital heart disease, CNS complications with

congestive heart failure

controversies in neurology

corpus callosum, lesion of

cranial nerve palsies

creatine phosphokinase(CPK)elevated

critical care unit

critical illness

cytomegalovirus infection

daclizumab

dehydration

delay in diagnosis

delayed muscle relaxation

delivery, complicated

demyelinating disease

dermatomyositis

developmental disability

developmental evaluation

differential diagnosis

diplopia

disability rating scale, neurological

disability, neurological

disease modifying agents

disseminated intravascular coagulation(DIC)

dizziness

drug abuse

drug holiday

drug induced neurologic disorders

drug withdrawal

dural arteriovenous malformation

dural sinus thrombosis

dyskinesia

efficacy

electrical injury of nervous system

electroencephalogram

electroencephalogram, abnormalities of

electroencephalogram, interictal

electromyogram

emergencies, neurologic

encephalitis

encephalitis, autoimmune

encephalitis, viral

encephalopathy

eosinophilia

epidemiology of neurology

epilepsy

episodic disorders

Epstein-Barr virus

Epstein-Barr virus, negative

ergotamine

etanercept

evidence-based research

exercise

eye movement, painful

fibrinolytic agents, complications

fine motor function, impaired

gammaglobulin therapy, intravenous

gender

gene

gene mutation

genetic neurologic disorders

gray matter

Guillain Barre syndrome

Guillain Barre syndrome, etiology of

head injury

head injury, pediatric

headache

headache, recurrent

headache, severe

headache, thunderclap

hearing loss

heat intolerance

heatstroke

heparin, low-molecular-weight

hepatic failure

hepatitis B vaccine

heralding manifestation

herniated disc

herniated disc, lumbar

herniated disc, lumbar-conservative vs.surgical treat.of

herniated disc, lumbar-laminectomy

herpes simplex encephalitis

herpes virus

herpes virus infection

herpes zoster

HLA

hormone replacement

hospital length of stay

hot bath test

human T-lymphotropic virus type I(HTLV-I)

hydrocephalus

hypereosinophilic syndrome(HES)

hyperglycemia

hypersensitivity reaction

hypertension

hyperthermia

hypertrophic intracranial pachymeningitis

hypotension, systemic

hypoxia

hypoxia, newborn

iatrogenic neurologic disorders

idiopathic thrombocytopenic purpura

imbalance

imbalance, postural

immune checkpoint inhibitors

immune reconstitution inflammatory syndrome

immune-related adverse events

immunization, neurologic complications with

immunofluorescence

immunologic disease

immunology and the nervous system

immunomodulation

immunosuppression

immunosuppressive agents

immunotherapy

in situ hybridization

incidence

inebilizumab

infection

infectious mononucleosis

infliximab

intellectual deficit

intelligence quotient

intelligence testing in children

intracerebral hemorrhage

intracerebral hemorrhage, lobar

intracranial hemorrhage

learning disability, in children

leg spasms

leg spasms, painful

levamisole

level of consciousness, decreased

life expectancy

limbic encephalitis

lipoprotein receptor-related protein 4

listeria monocytogenes

low back pain

low birth weight

lumbar puncture

lumbar puncture, indications for

lumbar spine manipulation

Lyme disease

lymphadenopathy

lymphoma

lymphoma, primary of CNS

malformation, vascular

malformation, vascular, cerebral

malignancy screen

malpractice

marihuana

medical-legal aspects of neurology

medication withdrawal

memory, impairment of

meningitis

meningitis, adults

meningitis, aseptic

meningitis, bacterial

meningitis, bacteriologic etiology of

meningitis, children

meningitis, clinical features of

meningitis, CSF cell count-normal

meningitis, CSF findings in

meningitis, factors influencing mortality in

meningitis, iatrogenic

meningitis, late neurologic sequelae in

meningitis, meningococcal

meningitis, neurologic aspects and complications of

meningitis, pneumococcal

meningitis, prophylaxis against

meningitis, spinal fluid smear and culture of

meningitis, treatment of

meningitis, treatment of, empirical

meningoencephalitis

menses

mental status, abnormal

mesial temporal sclerosis

migraine

migraine, pathogenesis

migraine, prophylaxis

migraine, treatment of

mimics

misdiagnosis

molecular genetics

monoclonal antibodies

monoclonal gammopathy

movement disorder, psychogenic

MRI, CAT scan compared to

MRI, cerebrovascular disease

MRI, contrast enhanced

MRI, demyelinating disease

MRI, diffusion weighted

MRI, early changes in CVA

MRI, false negative

MRI, field strength, high

MRI, incidental finding

MRI, lesion burden

MRI, magnetization transfer sequence

multiple sclerosis, aggressive

multiple sclerosis, children

multiple sclerosis, clinical patterns

multiple sclerosis, conjugal

multiple sclerosis, conversion to clinically definite

multiple sclerosis, diagnosis of

multiple sclerosis, diagnostic criteria

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, disease activity

multiple sclerosis, epidemiology of

multiple sclerosis, etiology of

multiple sclerosis, familial

multiple sclerosis, lesion location

multiple sclerosis, linoleic acid in

multiple sclerosis, monosymptomatic

multiple sclerosis, pathogenesis

multiple sclerosis, presenting manifestations

multiple sclerosis, prognosis

multiple sclerosis, prophylaxsis

multiple sclerosis, radiologically isolated syndrome

multiple sclerosis, relapsing

multiple sclerosis, risk factors for

multiple sclerosis, secondary progressive

multiple sclerosis, treatment of

multiple sclerosis, treatment of, first attack

myasthenia gravis, classification

myasthenia gravis, diagnosis

myasthenia gravis, drug induced

myasthenia gravis, etiology of

myasthenia gravis, ocular

myasthenia gravis, receptor site in

myasthenia gravis, seronegative

myasthenia gravis, thymectomy in

myasthenia gravis, treatment of

myasthenia gravis, variants

myasthenic crisis

myelitis

myelitis, transverse

myelitis, transverse, prognosis

myelopathy, transverse

myocarditis

myopathy

myopathy, critically ill

myotonia

nabiximols

natalizumab

natalizumab, discontinuation

negative

neisseria meningitis

neoplasm, primary of CNS

neoplasm, primary of CNS-children

nerve conduction studies

nerve growth factor

neuroendocrinology

neurofilament light chain protein

neurologic complications

neurologic complications of, systemic cancer

neurologic disease

neurologic disease, diagnoses of

neurologic evaluation

neurologic examination

neurologic signs

neurologic symptoms

neurological intensive care

neuromuscular disease, electrodiagnosis of

neuromuscular junction

neuromuscular junction, abnormality of

neuromyelitis optica (Devic's disease)

neuromyelitis optica spectrum disorder

neuropathology

neuropathology, brain

neuropathy

neuropathy, iatrogenic

neuropathy, immune

neuropathy, medication induced

neuropathy, motor, multifocal

neuropathy, painful

neuropathy, peripheral, treatment

neuroprotective agents

neurotoxic

newborn, evaluation of

nocardiosis

nonsteroidal anti-inflammatory drug

ocrelizumab

ofatumumab

old age, neurology of

ophthalmoplegia

opportunistic infection

opportunistic infection, CNS

optic neuritis

optic neuritis, bilateral

optic neuritis, children

optic neuritis, etiology of

optic neuritis, recurrent

optic neuritis, treatment of

oral contraceptives

oral contraceptives, neurologic complications with

organomegaly

pachymeningitis, cranial

paramyotonia congenita

Parkinson disease

pathologic reflex

patient information and support

percussion induced muscle contraction

Persistent postural-perceptual dizziness

personality change

pertussis immunization

plasmapheresis

plasmapheresis, complications of

pleocytosis of cerebrospinal fluid

pneumonia

POEMS syndrome

polymerase chain reaction

polymerase chain reaction, false negative

polymyositis

polyneuropathy, chronic inflammatory demyelinating

polyneuropathy, critically ill

posterior fossa, lesion of

posterior leukoencephalopathy syndrome

postpartum

practice guidelines

precipitating factors

pregnancy, neurologic complications in

premarin

premature infant

premature infant, problems in

prenatal

prethrombotic state

prevention of neurologic disorders

primary intracranial hypotension

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

psychological testing

psychological testing, children

rehabilitation for neurologic disorders

renal failure

respiratory tract infection

retinal hemorrhages

retinal lesion

retrovirus

reversible cerebral vasoconstrictive syndromes

reversible neurologic disorder

review article

rheumatoid arthritis

rheumatoid arthritis, neurologic complications of

risk factors

risk stratification

risk-benefit assessment

seizure, age of onset

seizure, complications following

seizure, diagnosis of

seizure, drug resistance

seizure, etiology of

seizure, febrile

seizure, focal

seizure, immunization causing

seizure, incidence of

seizure, intractable

seizure, intractable, treatment of

seizure, medication failure

seizure, neonatal

seizure, prognosis in childhood

seizure, surgical treatment of

seizure, treatment of

seizure, treatment of, polytherapy

seizure, treatment, adjunctive therapy

selective serotonin reuptake inhibitors

sensorineural hearing loss

serotonin norepinephrine reuptake inhibitors

shared decision making

sinusitis

skin, lesions in neurologic disorders

small vessel disease

sodium channel dysfunction

spasticity

spasticity, treatment of

spinal cord

spinal cord, lesion of

spinal manipulation

spirochete infection

status epilepticus

status epilepticus, nonconvulsive

stem cell transplantation

steroid

steroid therapy, CNS treatment and complications with

stimulation, deep brain

stress, emotional

stroke, progression of

subarachnoid hemorrhage

subarachnoid hemorrhage, cerebral convexity

subdural hematoma

subdural hematoma, neonates and infants

sun exposure

superior sagittal sinus thrombosis

systemic illness

T cell lymphocytes

temporal lobe, lesion

temporal lobe, lesion, bilateral

tick-borne encephalitis

tissue plasminogen activator, intravenous

toxoplasma gondii

transient ischemic attack

transient neurologic deficit

trauma

travel, foreign

treatment of neurologic disorder

trigeminovascular system

triptans

tumor necrosis factor

tumor necrosis factor inhibitor

twins

Uhthoff's syndrome

ultraviolet light

urinary tract infection

vaccination, neurologic complications with

vaccine

vagus nerve stimulation

varicella zoster virus

vascular malformation, children, intracranial

vasoconstrictive drugs

vision, failure of in childhood

visual field defect

visual loss

vitamin D

vitamin supplementation

water channel antibodies

weakness

weakness, fatiguable

weakness, generalized

Showing articles 50 to 100 of 9886 << Previous Next >>

Demographic and Clinical Characteristics of Malignant Multiple Sclerosis
Neurol 76:1996-2001, Gholipour, T.,et al, 2011

Hypereosinophilia in Patients with Multiple Sclerosis Treated with Natalizumab
Neurol 77:1561-1564, Abbas, M.,et al, 2011

Yellow Fever Vaccination and Increased Relapse Rate in Travelers with Multiple Sclerosis
Arch Neurol 68:1267-1271, Farez, M.F. and Correale, J., 2011

Multiple Sclerosis-Quenching the Flames of Inflammation
Lancet 378:1759-1760, , 2011

Management and Outcome of CSF-JC Virus PCR-negative PML in a Natalizumab-treated Patient with MS
Neurol 77:2010-2016, Kuhle, J.,et al, 2011

Immune Reconstitution Inflammatory Syndrome in Patients With Multiple Sclerosis Following Cessation of Natalizumab Therapy
Arch Neurol 68:186-191, Miravalle,A.,et al, 2011

Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy
Neurol 76:1697-1704, Vermersch,P.,et al, 2011

Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis
Neurol 76:1858-1865, OConnor, P.W.,et al, 2011

Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab
Ann Neurol 69:1060-1062, Phan-Ba, R.,et al, 2011

Reversible Cerebral Vasoconstruction Syndromes
Arch Neurol 68:1005-1012,976, Singhal, A.B.,et al, 2011

Drug-Resistant Epilepsy
NEJM 365:919-26, Kwan, P.,et al, 2011

Immune Reconstitution Inflammatory Syndrome in Natalizumab-Associated PML
Neurol 77:1061-1067,1033, Tan, I.L.,et al, 2011

Brainstem Lesion in Clinically Isolated Syndromes
Neurol 75:1933-1938, Tintore,M.,et al, 2010

Successful Management of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy and Immune Reconstitution Syndrome in a Patient With Multiple Sclerosis
Arch Neurol 67:1391-1394, Schr�der,A.,et al, 2010

Rapid Disease Course in African Americans With Multiple Sclerosis
Neurol 75:217-223, Kister,I., et al, 2010

Neonatal Cerebral Sinovenous Thrombosis From Symptom to Outcome
Stroke 41:1382-1388, Berfelo,F.J., et al, 2010

Safety and Efficacy of Natalizumab in Children With Multiple Sclerosis
Neurol 75:912-917, Ghezzi,A.,et al, 2010

Progressive Multifocal Leukoencephalopathy: Can We Reduce Risk in Patients Receiving Biological Immunomodulatory Therapies?
Ann Neurol 68:271-274, Tyler,K., 2010

Severe Cutaneous Candida Infection During Natalizumab Therapy in Multiple Sclerosis
Neurol 74:521-523, Gutwinski,S.,et al, 2010

Posterior Reversible Encephalopathy Syndrome After Rituximab Infusion in Neuromyelitis Optica
Neurol 74:1471-1473, S�nchez-Carteyron,A., et al, 2010

Natalizumab and Progressive Multifocal Leukoencephalopathy: What are the Causal Factors and Can It be Avoided?
Arch Neurol 67:923-930, Warnke,C., et al, 2010

Best Practice Recommendations for the Selection and Management of Patients with Multiple Sclerosis Receiving Natalizumab Therapy
Mutliple Sclerosis 15:S26-S36, Coyle,P.K.,et al, 2009

Progressive Multifocal Leukoencephalopathy After Natalizumab Monotherapy
NEJM 361:1081-1087, Linda,H.,et al, 2009

Treatment of Progressive Multifocal Leukoencephalopathy Associated with Natalizumab
NEJM 361:1075-1080, Wenning,W.,et al, 2009

Immunologic, Clinical, and Radiologic Status 14 Months After Cessation of Natalizumab Therapy
Neurol 72:396-401,392, Stuve,O.,et al, 2009

Incidental MRI Anomalies Suggestive of Multiple Sclerosis: The Radiologically Isolated Syndrome
Neurol 72:800-805,780, Okuda,D.T.,et al, 2009

Early MRI in Optic Neuritis: The Risk for Disability
Neurol 72:542-550, Swanton,.K.,et al, 2009

Pediatric Optic Neuritis: Brain MRI Abnormalities and Risk of Multiple Sclerosis
Neurol 72:881-885, Bonhomme,G.R.,et al, 2009

Hepatitis B Vaccine and the Risk of CNS Inflammatory Demyelination in Childhood
Neurol 72:873-880,870, Mikaeloff,Y.,et al, 2009

Multiple Sclerosis Therapeutics: Unexpected Outcomes Clouding Undisputed Successes
Neurol 72:1008-1015, Wiendl,H. &Hohlfeld,R., 2009

Opportunistic Infections and Other Risks with Newer Multiple Sclerosis Therapies
Ann Neurol 65:367-377, Berger,J.R. &Houff,S., 2009

Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis: A Comparative Study
Arch Neurol 66:593-599, Boster,A.,et al, 2009

Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab
Ann Neurol 66:403-406, 261, 262, Schweikert,A.,et al, 2009

B-Cell Depletion with Rituximab in Relapsing-Remitting Multiple Sclerosis
NEJM 358:676-688, Hauser,S.L.,et al, 2008

Postwithdrawal Rebound Increase in T2 Lesional Activity in Natalizumab-Treated MS Patients
Neurol 70:1150-1151,1073, Vellinga,M.M.,et al, 2008

Do Oligoclonal Bands Add Information to MRI in First Attacks of Multiple Sclerosis?
Neurol 70:1079-1083,1059, Tintore,M.,et al, 2008

Tick-Borne Encephalitis
Lancet 371:1861-1871, Lindquist,L. &Vapalahti,O., 2008

Mlutiple Sclerosis Risk After Optic Neuritis: Final Optic Neuritis Treatment Trial Follow-Up
Arch Neurol 65:727-732, The Optic Neuritis Study Group, 2008

Anti-Tumor Necrosis Factor Alpha-Associated Multiple Sclerosis
AJNR 26:1548-1550, Titelbaum,D.S.,et al., 2008

Assessment: The Use of Natalizumab (Tysabri) for the Treatment of Multiple Sclerosis (An Evidence-Based Review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 71:766-773, Goodin,D.S.,et al., 2008

Monoclonal Antibody Therapies and Neurologic Disorders
Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008

Multiple Sclerosis
Lancet 372:1502-1517, Compston,A. &Coles,A., 2008

Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
NEJM 359:1786-1801,1838, The CAMMS223 Trial Investigators, 2008

Natalizumab Use in Pediatric Multiple Sclerosis
Arch Neurol 65:1655-1658, Huppke,P.,et al, 2008

Intracranial Hemorrhage in Children
Arch Neurol 65:1629-1633, Lo,W.D.,et al, 2008

Risk Factors of Cerebral Vein and Sinus Thrombosis
Front Neurol Neurosci 23:23-54, de Freitas, G.R. & Bogousslavsky, J., 2008

Multiple Sclerosis After Infectious Mononucleosis
Arch Neurol 64:72-75, Nielsen,T.R.,et al, 2007

Quantifying the Risks and Benefits of Natalizumab in Relapsing Multiple Sclerosis
Neurol 68:1524-1528, Dorsey,E.R.,et al, 2007

Natalizumab for Multiple Sclerosis
NEJM 356:2622-2629, Ransohoff,R.M., 2007

Serum 25-Hydroxyvitamin D Levels and Risk of Multiple Sclerosis
JAMA 296:2832-2838, Munger,K.L.,et al, 2006

Showing articles 50 to 100 of 9886 << Previous Next >>